BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32985506)

  • 1. Interleukin-8 as a candidate for thymoma identification and recurrence surveillance.
    Gao S; Jiang J; Jin C; Gao J; Xiong D; Yang P; Cui S; Yang W; Leng Q; Dong J; Chen G; Liu J; Wang L; Ke A; Wang H; Ding J
    Nat Commun; 2020 Sep; 11(1):4881. PubMed ID: 32985506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the prognostic role of neutrophil-to-lymphocyte ratio following complete resection of thymoma.
    Muriana P; Carretta A; Ciriaco P; Bandiera A; Negri G
    J Cardiothorac Surg; 2018 Nov; 13(1):119. PubMed ID: 30454002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The cytomorphological, morphometric, and cytogenetic indices of malignant lymphoid thymoma].
    Bolgova LS; Alekseenko OI; Tuganova TN; Krotevich MS; Borisiuk BO
    Klin Lab Diagn; 2006 Jul; (7):46-7. PubMed ID: 16925066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miR-21-5p and miR-148a-3p as emerging non-invasive biomarkers in thymic epithelial tumors.
    Bellissimo T; Russo E; Ganci F; Vico C; Sacconi A; Longo F; Vitolo D; Anile M; Disio D; Marino M; Blandino G; Venuta F; Fazi F
    Cancer Biol Ther; 2016; 17(1):79-82. PubMed ID: 26575977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between anti-dsDNA titre increase and thymoma relapse.
    Cavagna L; Prisco E; Montecucco C; Caporali R
    Clin Exp Rheumatol; 2011; 29(3):599-600. PubMed ID: 21722507
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thymoma with extensive coagulative necrosis and high serum level of CYFRA 21-1; report of a case].
    Himuro N; Minakata T; Oshima Y; Tomita Y; Kataoka D; Kadokura M
    Kyobu Geka; 2014 Dec; 67(13):1205-7. PubMed ID: 25434553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypereosinophilia in a patient with invasive thymoma with clonal T-lymphocyte expansion expressing CD4, CD8, and CD25 antigens.
    Sumi M; Nunoda K; Mizutani T; Ishii Y; Gotoh A; Kimura Y; Suga Y; Ohira T; Miyajima K; Serizawa H; Mukai K; Kato H; Ohyashiki K
    Int J Hematol; 2006 Apr; 83(3):243-6. PubMed ID: 16720555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of p16
    Aesif SW; Aubry MC; Yi ES; Kloft-Nelson SM; Jenkins SM; Spears GM; Greipp PT; Sukov WR; Roden AC
    J Thorac Oncol; 2017 May; 12(5):860-871. PubMed ID: 28179162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymoma with hypersecretion of thymic hormone.
    Chollet P; Plagne R; Fonck Y; Chassagne J; Bétail G; Dardenne M; Bach JF
    Thymus; 1981 Dec; 3(6):321-34. PubMed ID: 6976649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathologic analysis of 52 cases of thymic epithelial tumor].
    Ma YQ; Miao N; Abulajiang G; Li QX; Liu X; Zhang W; Wang CF; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):249-54. PubMed ID: 20654124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of the preoperative neutrophil-to-lymphocyte ratio for complete resection of thymoma.
    Yanagiya M; Nitadori JI; Nagayama K; Anraku M; Sato M; Nakajima J
    Surg Today; 2018 Apr; 48(4):422-430. PubMed ID: 29063371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in thymoma imaging.
    Marom EM
    J Thorac Imaging; 2013 Mar; 28(2):69-80; quiz 81-3. PubMed ID: 23422781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Neutrophil Count as a Negative Prognostic Factor for Relapse in Patients with Thymic Epithelial Tumor.
    Okada S; Shimomura M; Tsunezuka H; Ishihara S; Ikebe S; Furuya T; Shimada J; Teramukai S; Inoue M
    Ann Surg Oncol; 2020 Jul; 27(7):2438-2447. PubMed ID: 31993857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma.
    Kishibuchi R; Kondo K; Soejima S; Tsuboi M; Kajiura K; Kawakami Y; Kawakita N; Sawada T; Toba H; Yoshida M; Takizawa H; Tangoku A
    Int J Oncol; 2020 Jan; 56(1):315-326. PubMed ID: 31746370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis.
    Janik S; Bekos C; Hacker P; Raunegger T; Ghanim B; Einwallner E; Beer L; Klepetko W; Müllauer L; Ankersmit HJ; Moser B
    Oncotarget; 2017 Jul; 8(29):47090-47102. PubMed ID: 28514756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic signature of seven genes for the prediction in patients with thymoma.
    Li Q; Su YL; Shen WX
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):109-116. PubMed ID: 30328513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of recurrent thymoma: is it worthwhile?†.
    Marulli G; Margaritora S; Lucchi M; Cardillo G; Granone P; Mussi A; Carleo F; Perissinotto E; Rea F
    Eur J Cardiothorac Surg; 2016 Jan; 49(1):327-32. PubMed ID: 25755187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation of tumour-related genes in thymic epithelial tumours.
    Hirose Y; Kondo K; Takizawa H; Nagao T; Nakagawa Y; Fujino H; Toba H; Kenzaki K; Sakiyama S; Tangoku A
    Lung Cancer; 2009 May; 64(2):155-9. PubMed ID: 18778870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of thymoma: clinicopathological features, re-operation, and outcome.
    Haniuda M; Kondo R; Numanami H; Makiuchi A; Machida E; Amano J
    J Surg Oncol; 2001 Nov; 78(3):183-8. PubMed ID: 11745803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent thymoma: evidence for histological progression.
    Pescarmona E; Rendina EA; Venuta F; Ricci C; Baroni CD
    Histopathology; 1995 Nov; 27(5):445-9. PubMed ID: 8575735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.